
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $76.7M | -- | -- | $0.66 | -- |
07/24/2025 | Q2 | $76.2M | -- | -- | $0.63 | -- |
04/30/2025 | Q1 | $72.6M | $75.9M | $0.57 | $0.55 | $0.02 |
01/23/2025 | Q4 | $73.6M | $136.6M | -$2.52 | $0.67 | -$3.19 |
10/24/2024 | Q3 | $73.1M | $72.4M | $0.74 | $0.64 | $0.10 |
07/25/2024 | Q2 | $74.8M | $71.5M | $0.20 | $0.70 | -$0.50 |
04/25/2024 | Q1 | $74.9M | $75.9M | $0.53 | $0.72 | -$0.19 |
01/25/2024 | Q4 | $75.5M | $77.5M | $0.83 | $0.79 | $0.04 |
10/26/2023 | Q3 | -- | -- | $0.71 | $0.77 | -$0.06 |
07/27/2023 | Q2 | -- | -- | $0.86 | $0.80 | $0.06 |
04/27/2023 | Q1 | -- | -- | $0.86 | $0.82 | $0.04 |
01/26/2023 | Q4 | -- | -- | $1.31 | $0.92 | $0.39 |
10/20/2022 | Q3 | -- | -- | $1.04 | $1.01 | $0.03 |
07/28/2022 | Q2 | -- | -- | $0.97 | $0.93 | $0.04 |
04/28/2022 | Q1 | -- | -- | $0.92 | $0.86 | $0.06 |
01/27/2022 | Q4 | -- | -- | $1.02 | $0.90 | $0.12 |
10/28/2021 | Q3 | -- | -- | $0.86 | $0.84 | $0.02 |
07/22/2021 | Q2 | -- | -- | $0.88 | $0.84 | $0.04 |
04/22/2021 | Q1 | -- | -- | $0.81 | $0.84 | -$0.03 |
01/28/2021 | Q4 | -- | -- | $0.36 | $0.62 | -$0.26 |
10/22/2020 | Q3 | -- | -- | $0.00 | $0.53 | -$0.53 |
07/23/2020 | Q2 | -- | -- | $0.53 | $0.27 | $0.26 |
04/23/2020 | Q1 | -- | -- | $0.06 | $0.55 | -$0.49 |
01/23/2020 | Q4 | -- | -- | $0.51 | $0.71 | -$0.20 |
10/24/2019 | Q3 | -- | -- | $0.51 | $0.66 | -$0.15 |
07/25/2019 | Q2 | -- | -- | $0.66 | $0.65 | $0.02 |
04/25/2019 | Q1 | -- | -- | $0.58 | $0.54 | $0.04 |
01/24/2019 | Q4 | -- | -- | $0.67 | $0.65 | $0.02 |
10/25/2018 | Q3 | -- | -- | $0.64 | $0.64 | $0.01 |
07/26/2018 | Q2 | -- | -- | $0.59 | $0.56 | $0.03 |
04/26/2018 | Q1 | -- | -- | $0.52 | $0.49 | $0.03 |
01/25/2018 | Q4 | -- | -- | $0.42 | $0.54 | -$0.12 |
10/26/2017 | Q3 | -- | -- | $0.49 | $0.58 | -$0.09 |
07/27/2017 | Q2 | -- | -- | $0.51 | $0.57 | -$0.06 |
04/27/2017 | Q1 | -- | -- | $0.57 | $0.53 | $0.04 |
Midland States Bancorp reported $75.9M worth of top line sales in its most recent quarter.
Midland States Bancorp announced earnings per share of $0.57 which represents a beat of analyst forecast a $0.55 per share.
Midland States Bancorp reported -- that represents -- per share over the last quarter.
Midland States Bancorp's earnings are forecast to grow from $1.32 per share to $2.15 per share next year representing an increase of 89.9%.
Midland States Bancorp's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.